Exact Mass: 523.2066884000001

Exact Mass Matches: 523.2066884000001

Found 27 metabolites which its exact mass value is equals to given mass value 523.2066884000001, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Pralnacasan

N-{4-[(2-ethoxy-5-oxooxolan-3-yl)carbamoyl]-6,10-dioxo-hexahydro-1H-pyridazino[1,2-a][1,2]diazepin-7-yl}isoquinoline-1-carboxamide

C26H29N5O7 (523.2066884000001)


   

Asp Phe Gly Trp

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Phe Trp Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Gly Phe Trp

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Gly Trp Phe

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Trp Phe Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Asp Trp Gly Phe

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Asp Gly Trp

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Asp Trp Gly

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Gly Asp Trp

(3S)-3-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Gly Trp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Phe Trp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Phe Trp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Gly Asp Phe Trp

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Asp Trp Phe

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Phe Asp Trp

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Phe Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Gly Trp Asp Phe

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Gly Trp Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Trp Asp Phe Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Asp Gly Phe

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-[({[(1S)-1-carboxy-2-phenylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Phe Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Phe Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]acetamido}butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Trp Gly Asp Phe

(3S)-3-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C26H29N5O7 (523.2066884000001)


   

Trp Gly Phe Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-phenylpropanamido]butanedioic acid

C26H29N5O7 (523.2066884000001)


   

Pralnacasan

Pralnacasan

C26H29N5O7 (523.2066884000001)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

VX-740;Hmr 3480

VX-740;Hmr 3480

C26H29N5O7 (523.2066884000001)